BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nard FD, Todoerti M, Grosso V, Monti S, Breda S, Rossi S, Montecucco C, Caporali R. Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs. World J Hepatol 2015; 7(3): 344-361 [PMID: 25848463 DOI: 10.4254/wjh.v7.i3.344]
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/344.htm
Number Citing Articles
1
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host2016; : 69 doi: 10.1128/9781555819040.ch3
2
M. Elaine Husni. Comorbidities in Psoriatic ArthritisRheumatic Disease Clinics of North America 2015; 41(4): 677 doi: 10.1016/j.rdc.2015.07.008
3
Marco Sebastiani, Fabiola Atzeni, Laura Milazzo, Luca Quartuccio, Carlo Scirè, Giovanni Battista Gaeta, Giovanni Lapadula, Orlando Armignacco, Marcello Tavio, Ignazio Olivieri, Pierluigi Meroni, Laura Bazzichi, Walter Grassi, Alessandro Mathieu, Claudio Mastroianni, Evangelista Sagnelli, Teresa Santantonio, Caterina Uberti Foppa, Massimo Puoti, Loredana Sarmati, Paolo Airò, Oscar Massimiliano Epis, Rossana Scrivo, Miriam Gargiulo, Agostino Riva, Andreina Manfredi, Giovanni Ciancio, Gianguglielmo Zehender, Gloria Taliani, Luca Meroni, Salvatore Sollima, Piercarlo Sarzi-Puttini, Massimo Galli. Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienneRevue du Rhumatisme 2018; 85(2): 115 doi: 10.1016/j.rhum.2017.09.001
4
Stefano Piaserico, Andrea Conti, Ilaria Coati, Giovanna Galdo, Veronica Bernabucci, Andrea Zanca, Marina Drabeni, Flora Masutti, Maria L. Musumeci, Alfredo Alberti, Francesco P. Russo. Use of ustekinumab in five psoriatic patients with hepatitis B virus infectionGiornale Italiano di Dermatologia e Venereologia 2019; 154(3) doi: 10.23736/S0392-0488.17.05487-6
5
Stefano Piaserico, Francesco Messina, Francesco Paolo Russo. Managing Psoriasis in Patients with HBV or HCV Infection: Practical ConsiderationsAmerican Journal of Clinical Dermatology 2019; 20(6): 829 doi: 10.1007/s40257-019-00457-3
6
Rajesh Gopalarathinam, Mais Arwani, Mary Chester M. Wasko, Tarun S. Sharma. Comorbidity in Rheumatic Diseases2017; : 1 doi: 10.1007/978-3-319-59963-2_1
7
İlkay Bozkurt, Ahmet Bektaş. Anti-TNF alfa kullanan hastalarda hepatit B reaktivasyonunun değerlendirilmesiDicle Tıp Dergisi 2019; : 553 doi: 10.5798/dicletip.620594
8
Wiebke Kathmann. Rheuma und InfektionenOrthopädie & Rheuma 2016; 19(2): 15 doi: 10.1007/s15002-016-0866-8
9
Sultan M. Almogairen. Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in miceBMC Pharmacology and Toxicology 2019; 20(1) doi: 10.1186/s40360-019-0303-0
10
Jung Il Lee. Reactivation of Hepatitis B Virus in Patients with Rheumatologic Disease Treated with Biologic Disease Modifying Anti-rheumatic Drugs: Screening and TreatmentJournal of Rheumatic Diseases 2015; 22(5): 282 doi: 10.4078/jrd.2015.22.5.282
11
Tatyana P. Makalish, Ilya O. Golovkin, Volodymyr V. Oberemok, Kateryna V. Laikova, Zenure Z. Temirova, Olesya A. Serdyukova, Ilya A. Novikov, Roman A. Rosovskyi, Andrey I. Gordienko, Evgeniya Yu. Zyablitskaya, Elvina A. Gafarova, Kseniya A. Yurchenko, Iryna I. Fomochkina, Anatoly V. Kubyshkin. Anti-Rheumatic Effect of Antisense Oligonucleotide Cytos-11 Targeting TNF-α ExpressionInternational Journal of Molecular Sciences 2021; 22(3): 1022 doi: 10.3390/ijms22031022
12
Takako Inoue, Takeshi Matsui, Yasuhito Tanaka. Novel strategies for the early diagnosis of hepatitis B virus reactivationHepatology Research 2021;  doi: 10.1111/hepr.13699
13
Josef S Smolen, Daniel Aletaha, Iain B McInnes. Rheumatoid arthritisThe Lancet 2016; 388(10055): 2023 doi: 10.1016/S0140-6736(16)30173-8
14
Melissa Padovan, Matteo Filippini, Angela Tincani, Elisabetta Lanciano, Eleonora Bruschi, Oscar Epis, Pietro Garau, Alessandro Mathieu, Eleonora Celletti, Leopoldo Giani, Paola Tomietto, Fabiola Atzeni, Piercarlo Sarzi Puttini, Francesca Zuliani, Salvatore De Vita, Francesco Trotta, Anastasio Grilli, Massimo Puoti, Marcello Govoni. Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus InfectionArthritis Care & Research 2016; 68(6): 738 doi: 10.1002/acr.22786
15
Jean-Luc Davignon, Benjamin Rauwel, Yannick Degboé, Arnaud Constantin, Jean-Fredéric Boyer, Andrey Kruglov, Alain Cantagrel. Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a reviewArthritis Research & Therapy 2018; 20(1) doi: 10.1186/s13075-018-1725-6
16
Barbara E. Ostrov, Daniel Amsterdam. Interplay of Anti-Viral Vaccines with Biologic Agents and Immunomodulators in Individuals with Autoimmune and Autoinflammatory DiseasesImmunological Investigations 2021; 50(7): 833 doi: 10.1080/08820139.2021.1900863
17
Florian MORETTO, François-Xavier CATHERINE, Clémentine ESTEVE, Mathieu BLOT, Lionel PIROTH. Isolated Anti-HBc: Significance and ManagementJournal of Clinical Medicine 2020; 9(1): 202 doi: 10.3390/jcm9010202
18
Ingrid Becker, Gerd Horneff. Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology RegistryArthritis Care & Research 2017; 69(4): 552 doi: 10.1002/acr.22961
19
Lesia K. Dropulic, Howard M. Lederman. Diagnostic Microbiology of the Immunocompromised Host2016; : 1 doi: 10.1128/9781555819040.ch1
20
Manuel Pombo-Suarez, Juan J. Gomez-Reino. Infections in Systemic Autoimmune Diseases: Risk Factors and ManagementHandbook of Systemic Autoimmune Diseases 2020; 16: 179 doi: 10.1016/B978-0-444-64217-2.00009-9
21
Chak Sing Lau, Faith Chia, Leonila Dans, Andrew Harrison, Tsu Yi Hsieh, Rahul Jain, Seung Min Jung, Mitsumasa Kishimoto, Ashok Kumar, Khai Pang Leong, Zhanguo Li, Juan Javier Lichauco, Worawit Louthrenoo, Shue Fen Luo, Rong Mu, Peter Nash, Chin Teck Ng, Bagus Suryana, Linda Kurniaty Wijaya, Swan Sim Yeap. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritisInternational Journal of Rheumatic Diseases 2019; 22(3): 357 doi: 10.1111/1756-185X.13513
22
S. Piaserico, P. Dapavo, A. Conti, P. Gisondi, F.P. Russo. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literatureJournal of the European Academy of Dermatology and Venereology 2017; 31(11): 1853 doi: 10.1111/jdv.14146
23
Roberto Caporali, Gloria Crepaldi, Veronica Codullo, Francesca Benaglio, Sara Monti, Monica Todoerti, Carlomaurizio Montecucco. 20 years of experience with tumour necrosis factor inhibitors: what have we learned?Rheumatology 2018; 57(Supplement_7): vii5 doi: 10.1093/rheumatology/key059
24
C. Papeix, C. Donze, C. Lebrun-Frénay, C. Papeix, C. Donzé, C. Lebrun-Frénay, D. Laplaud, E. Thouvenot, X. Ayrignac, V. Pourcher-Martinez, H. Zéphir, J. de Seze, L. Michel, C. Bensa, C. Cara-Dalliere, A.M. Guen-noc, O. Casez, A. Maarouf, B. Bourre, A. Kwiatkowski, M. Cohen, E. Maillart, N. Collongues, C. Louapre, G. Androdias, A. Guegen, B. Audoin, G. Mattey, P. Bernady, J.M. Faucheux, P. Labauge, C. Meckies, B. Stankoff, P. Tourniaire, A. Dinh, A.M. Guennoc, F. Durnad-Dubief, S. Wiertlewski, N. Derache, E. Le page, S. Pittion, S. Vukusic, P. Clavelou, O. Heinzlef, R. Colamarino, E. Planque, A. Rico, C. Sheiber nogueira, M. de Seze, J. Ciron, H. Alchaar, D. Bensmail, D. Biotti, P. Branger, B. Brochet, B. Castan, A. Creange, E. Creisson, T. DeBroucker, R. Depaz, X. Douay, C. Dulau, M. Faucher, M. Fournier, A. Fromont, P. Gallien, O. Gout, J. Grimaud, Y. Hervé, A. Kerbrat, L. Kremer, L. Lanotte, L. Magy, A. Mania, A. Maurousset, X. Moisset, A. Montcuquet, T. Moreau, N. Morel, I. Patry, D. Peaureaux, M.C. Pouget, A. Ruet, C. Saint-Val, J.P. Stahl, F. Taithe, P. Tattevin, M. Vaillant, F. Vuoto. Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis SocietyRevue Neurologique 2021;  doi: 10.1016/j.neurol.2021.04.011
25
Ivan Noreña, Mario Fernández-Ruiz, José María Aguado. Viral infections in the biologic therapy eraExpert Review of Anti-infective Therapy 2018; 16(10): 781 doi: 10.1080/14787210.2018.1521270
26
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and DMicrobiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
27
Yasuhiro Otaki, Makiko DaSilva Ishida, Yuichi Saito, Yasuaki Oyama, Giichiro Oiso, Mitsuru Moriyama. Analysis of Closed Claims in the Clinical Management of Rheumatoid Arthritis in JapanChinese Medical Journal 2017; 130(12): 1454 doi: 10.4103/0366-6999.207479
28
C. Iking-Konert, W.-J. Mayet, S. Kuchen, J. Jenewein, S. Büchi, H. Zeidler, B. Michel. Differenzialdiagnose rheumatischer Erkrankungen2019; : 363 doi: 10.1007/978-3-662-56575-9_10
29
Christiane Gasperi, Olaf Stüve, Bernhard Hemmer. B cell-directed therapies in multiple sclerosisNeurodegenerative Disease Management 2016; 6(1): 37 doi: 10.2217/nmt.15.67
30
Marcia A. Friedman, Kevin L. Winthrop. Vaccines and Disease-Modifying Antirheumatic DrugsRheumatic Disease Clinics of North America 2017; 43(1): 1 doi: 10.1016/j.rdc.2016.09.003
31
Ying-Ming Chiu, Der-Yuan Chen. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologicsExpert Review of Clinical Immunology 2020; 16(2): 207 doi: 10.1080/1744666X.2019.1705785
32
Arman Zakaryan, Knarik Ginosyan. Perioperative Management of Patients With Ankylosing Spondylitis Undergoing Spine SurgeryFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01017
33
Turki Alameel, Eman Al Sulais. Risk of HBV Reactivation Among IBD patients With Occult Hepatitis B Virus InfectionClinical Gastroenterology and Hepatology 2021; 19(3): 621 doi: 10.1016/j.cgh.2020.04.089
34
Benjamin Chaigne, Hervé Watier. Theranostic of biopharmaceuticalsPharmacology & Therapeutics 2017; 175: 67 doi: 10.1016/j.pharmthera.2017.02.035
35
Florian Thalhammer. Biologika und Infektionenrheuma plus 2016; 15(2): 42 doi: 10.1007/s12688-016-0066-2
36
Yong Kwang Park, Eun-Sook Park, Doo Hyun Kim, Sung Hyun Ahn, Seung Hwa Park, Ah Ram Lee, Soree Park, Hong Seok Kang, Ji-Hyun Lee, Jong Man Kim, Suk-Koo Lee, Keo-Heun Lim, Nathalie Isorce, Shuping Tong, Fabien Zoulim, Kyun-Hwan Kim. Cleaved c-FLIP mediates the antiviral effect of TNF-α against hepatitis B virus by dysregulating hepatocyte nuclear factorsJournal of Hepatology 2016; 64(2): 268 doi: 10.1016/j.jhep.2015.09.012
37
Mariantonietta Pisaturo, Giovanni Di Caprio, Federica Calò, Federica Portunato, Salvatore Martini, Nicola Coppola. Management of HBV reactivation in non-oncological patientsExpert Review of Anti-infective Therapy 2018; 16(8): 611 doi: 10.1080/14787210.2018.1505501
38
Marcia A. Friedman, Kevin Winthrop. Vaccinations for rheumatoid arthritisCurrent Opinion in Rheumatology 2016; 28(3): 330 doi: 10.1097/BOR.0000000000000281
39
Joe Sasadeusz, Andrew Grigg, Peter D. Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G. Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G. Gish, Kumar Visvanathan. Screening and Prophylaxis to Prevent Hepatitis B ReactivationClinics in Liver Disease 2019; 23(3): 521 doi: 10.1016/j.cld.2019.04.012
40
Marco Biolato, Assunta Bianco, Matteo Lucchini, Antonio Gasbarrini, Massimiliano Mirabella, Antonio Grieco. The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative ReviewCNS Drugs 2021; 35(8): 861 doi: 10.1007/s40263-021-00842-9
41
Marco Sebastiani, Fabiola Atzeni, Laura Milazzo, Luca Quartuccio, Carlo Scirè, Giovanni Battista Gaeta, Giovanni Lapadula, Orlando Armignacco, Marcello Tavio, Ignazio Olivieri, Pierluigi Meroni, Laura Bazzichi, Walter Grassi, Alessandro Mathieu, Claudio Mastroianni, Evangelista Sagnelli, Teresa Santantonio, Caterina Uberti Foppa, Massimo Puoti, Loredana Sarmati, Paolo Airò, Oscar Massimiliano Epis, Rossana Scrivo, Miriam Gargiulo, Agostino Riva, Andreina Manfredi, Giovanni Ciancio, Gianguglielmo Zehender, Gloria Taliani, Luca Meroni, Salvatore Sollima, Piercarlo Sarzi-Puttini, Massimo Galli. Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritisJoint Bone Spine 2017; 84(5): 525 doi: 10.1016/j.jbspin.2017.05.013
42
Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, Tsu-Yi Hsieh, Yi-Ming Chen, Josef S Smolen, Gerd Burmester, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao, Mark C Genovese. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritisRMD Open 2020; 6(1): e001095 doi: 10.1136/rmdopen-2019-001095
43
Md Yuzaiful Md Yusof, Edward M. Vital, Maya H. Buch. B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During UseCurrent Rheumatology Reports 2015; 17(10) doi: 10.1007/s11926-015-0539-7
44
Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Mei-Ping Liu, Yin-Tzu Hsue, Ming-Hui Hung, Ying-Ming Chiu. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort studyArthritis Research & Therapy 2018; 20(1) doi: 10.1186/s13075-018-1748-z
45
Lesia K. Dropulic, Howard M. Lederman, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Overview of Infections in the Immunocompromised HostMicrobiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0026-2016
46
Maria R Ciardi, Marco Iannetta, Maria A Zingaropoli, Romina Salpini, Marianna Aragri, Rosanna Annecca, Simona Pontecorvo, Marta Altieri, Gianluca Russo, Valentina Svicher, Claudio M Mastroianni, Vincenzo Vullo. Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple SclerosisOpen Forum Infectious Diseases 2019; 6(1) doi: 10.1093/ofid/ofy356